EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing

Manon C Bouwmeester iD, Yu Tao, Susana Proença iD, Frank G van Steenbeek iD, Roos-Anne Samsom, Sandra M Nijmeijer, Theo Sinnige, Luc J W van der Laan iD, Juliette Legler iD, Kerstin Schneeberger iD, Nynke I Kramer iD, Bart Spee iD

Molecules · 07.01.2023 · 28 (2) · 621

DOI: 10.3390/molecules28020621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 07.01.2023. Verfasst von Manon C Bouwmeester und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Faculty of Veterinary Medicine, Regenerative Medicine Center Utrecht, Utrecht University, 3584 CT Utrecht, The Nethe…. Hauptthemen laut MEDLINE: Acetaminophen, Hepatocytes, Organoids. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging advances in the field of in vitro toxicity testing attempt to meet the need for reliable human-based safety assessment in drug development. Intrahepatic cholangiocyte organoids (ICOs) are described as a donor-derived in vitro model for disease modelling and regenerative medicine. Here, we explored the potential of hepatocyte-like ICOs (HL-ICOs) in in vitro toxicity testing by exploring the expression and activity of genes involved in drug metabolism, a key determinant in drug-induced toxicity, and the exposure of HL-ICOs to well-known hepatotoxicants. The current state of drug metabolism in HL-ICOs showed levels comparable to those of PHHs and HepaRGs for CYP3A4; however, other enzymes, such as CYP2B6 and CYP2D6, were expressed at lower levels. Additionally, EC50 values were determined in HL-ICOs for acetaminophen (24.0–26.8 mM), diclofenac (475.5–>500 µM), perhexiline (9.7–>31.5 µM), troglitazone (23.1–90.8 µM), and valproic acid (>10 mM). Exposure to the hepatotoxicants showed EC50s in HL-ICOs comparable to those in PHHs and HepaRGs; however, for acetaminophen exposure, HL-ICOs were less sensitive. Further elucidation of enzyme and transporter activity in drug metabolism in HL-ICOs and exposure to a more extensive compound set are needed to accurately define the potential of HL-ICOs in in vitro toxicity testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenHepatocytesOrganoidsHumansCytochrome P-450 CYP3ALiverToxicity Tests

Stichwörter der Autor:innen

drug-induced liver injuryhepatic in vitro modelhepatocyte-like cellshepatotoxicityintrahepatic cholangiocyte organoids

Substanzen

AcetaminophenCytochrome P-450 CYP3A

Autor:innen und Institutionen

  • Department of Clinical Sciences, Faculty of Veterinary Medicine, Regenerative Medicine Center Utrecht, Utrecht University, 3584 CT Utrecht, The Netherlands.
  • Division of Toxicology, Wageningen University, 6700 EA Wageningen, The Netherlands.
  • Institute for Risk Assessment Sciences, Utrecht University, 3584 CM Utrecht, The Netherlands.
  • Department of Cardiology, Division Heart & Lungs, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands.
  • Department of Surgery, Erasmus MC Transplant Institute, University Medical Center Rotterdam, 3015 CN Rotterdam, The Netherlands.

ORCID-Profile: Manon C Bouwmeester, Susana Proença, Frank G van Steenbeek, Luc J W van der Laan, Juliette Legler, Kerstin Schneeberger, Nynke I Kramer, Bart Spee

Förderung

  • Dutch Research Council

Zitieren

APA

Bouwmeester, M. C., Tao, Y., Proença, S., van Steenbeek, F. G., Samsom, R. A., Nijmeijer, S. M., Sinnige, T., van der Laan, L. J. W., Legler, J., Schneeberger, K., Kramer, N. I., & Spee, B. (2023). Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing. Molecules, 28(2), 621. https://doi.org/10.3390/molecules28020621

Vancouver

Bouwmeester MC, Tao Y, Proença S, van Steenbeek FG, Samsom RA, Nijmeijer SM, et al. Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing. Molecules. 2023;28(2):621. doi:10.3390/molecules28020621

BibTeX
@article{Bouwmeester2023,
  author = {Bouwmeester, Manon C and Tao, Yu and Proença, Susana and van Steenbeek, Frank G and Samsom, Roos-Anne and Nijmeijer, Sandra M and Sinnige, Theo and van der Laan, Luc J W and Legler, Juliette and Schneeberger, Kerstin and Kramer, Nynke I and Spee, Bart},
  title = {Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {2},
  pages = {621},
  doi = {10.3390/molecules28020621}
}
Kostenlos starten →